Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Dr. Reddy’s, TR-Pharm in Biosimilars Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Dr. Reddy’s, TR-Pharm in Biosimilars Alliance

To develop and commercialize three biosimilars in Turkey

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Reddy’s and TR-Pharm have entered a strategic collaboration agreement for three biosimilars, under which three products will be registered and subsequently commercialized by TR-Pharm in Turkey. TR-Pharm will also manufacture the drug substance and drug product upon completion of its facility investment.
 
TR-Pharm has begun working on the technology transfer. This collaboration will be an important part of TR-Pharm’s ongoing biologic product development and manufacturing business in the region. The partnership also allows Dr. Reddy’s to expand the global footprint of its biosimilar business.
 
Mehmet Göker, general manager of TR-Pharm, said, “Biosimilars are a key component of our investment strategy in Turkey to establish biotechnological API production for national use and regional exports. This agreement will not only enable more affordable medication but also support our research and development initiatives by building expertise within the country. We are pleased to have already started laying out the groundwork for manufacturing with Dr. Reddy’s for high quality biosimilar products.”
 
M V Ramana, executive vice president and head Branded Markets at Dr. Reddy’s, said, “Turkey is a key emerging market and we are pleased to partner with TR-Pharm to ensure that patients in the region get access to our portfolio of high quality biosimilar products. Dr. Reddy’s remains committed to providing access to affordable and innovative drugs to populations around the world, and this partnership will make this happen in Turkey.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics